2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Protara Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b) TARA-002 - Non-muscle Invasive Bladder Cancer | Phase 1 | Completed | Protara Therapeutics | 10 | 2023-05-08 | 2025-01-27 |
| Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a) TARA-002 - Non-muscle Invasive Bladder Cancer | Phase 1 | Completed | Protara Therapeutics | 12 | 2022-03-10 | 2025-01-27 |
Carcinoma in Situ (2) · Non-Muscle Invasive Bladder Neoplasms (2) · Urinary Bladder Neoplasms (2)
United States (2) · Moldova (1) · Romania (1) · Ukraine (1)